METHODS: In this study, the membrane was made of chitosan with several crosslinking agents such as Tripolyphosphate (TPP). In addition, calcium ion bonds are expected to increase the interaction with urea fertilizer through the encapsulation process.
THE RESULTS: Our data showed that urea slow-release fertilizer (SRF) with the chitosan/TPP/Ca membrane, was successfully synthesized. This membrane has the characteristics of a thin white layer that is transparent. The physical and chemical characterization of SRF membranes with various coating membrane variations showed that the chitosan/TPP/Ca-urea membrane has Young's modulus of 7.75-22.05 N/mm2, swelling of 109.52-132.62 % and porosity of 0.756-1.06 %. Functional group analysis shows that several spectral changes indicate the presence of crosslinking process between the chitosan functional groups and TPP. The urea release results show that the membrane is released through a diffusion mechanism. Furthermore, SEM results show that these membranes have pores with various shapes and sizes.
CONCLUSION: Based on the result, it can be concluded that chitosan membrane modification with the addition of TPP and calcium oxide provides improved membrane characteristic cs including degree of development, hydrophobicity, membrane stress, and nitrogen release on the membrane. This membrane shows is indicating suitability as a slow-release fertilizer.
PURPOSE: Investigation of the in vivo chemopreventive has the potential of nano Z. officinale Roscoe (Zo-NPs) in breast cancer.
STUDY DESIGN: Using female Mus musculus Balb/c induced with benzo[α]pyrene, the chemopreventive action of Z. officinale Roscoe. nanoencapsulated using κ-carrageenan was assessed.
RESULTS: Z. officinale Roscoe Extract. contains 58 compounds, with the main component being [6]-gingerol with [6]-gingerol content being 697.65 ± 8.52 mg/g extract. Nanoencapsulation of Z. officinale Roscoe. has been successfully prepared with a particle size of 483.30 ± 11.23 nm. Zo-NPs are generally resistant to pH, temperature, and salt content variations. Compared to group C1, which underwent ductular dilatation, the administration of Zo-NPs (group T2) to female Mus musculus Balb/c, induced by benzo[α]pyrene, revealed no histological alterations in breast tissue. Moreover, administering Zo-NPs can raise blood serum levels of CAT, GSH, and SOD. In addition, it showed a greater ability to lower TNF-α levels than the T1 group, which received Z. officinale Roscoe extract. (Zo).